The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ENTA FINANCIAL STATEMENTS

Enanta Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ENTAEnanta Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue65.3 M $Gross Profit15.1 M $ · 23%Operating Income-58.7 M $ · -90%Pre-tax Income-63.1 M $ · -97%Net Income to Owners-63.2 M $ · -97%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue65.3 M $+0.7%
Gross Profit15.1 M $-76.7%
Operating Income-58.7 M $—
EBITDA-70.1 M $—
Net Income to Owners-63.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets296.9 M
  • Equity101.1 M $34%
  • Current Liabilities54.2 M $18%
  • Long-term Liabilities141.6 M $48%

Key Figures

YoY change
Total Assets296.9 M $-1.4%
Total Liabilities195.8 M $-11.7%
Total Equity101.1 M $+27.5%
Cash & ST Investments189.5 M $-7.2%
Total Debt55.7 M $-73.1%
Net Debt22.2 M $-86.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-60 M-40 M-20 M0-25.3 M $Operating-33.1 M $Investing48.5 M $Financing-9.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-25.3 M $—
Capital Expenditures1.6 M $-92.1%
Free Cash Flow-27 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ENTA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.